Patrick N. Harris
Brisbane, QLD 4000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 309 publications
Novel transposon Tn8026 contributes to the global spread of transmissible linezolid resistance in Enterococcus via a linear plasmid.
Journal: Microbial genomics
Published: July 29, 2026
Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).
Journal: Microbiology spectrum
Published: July 15, 2026
The Queensland Bloodstream Infections (QBSI) study: rationale, protocol development and future directions.
Journal: Infectious diseases (London, England)
Published: June 17, 2026
Carbapenemases: epidemiology, detection and management in a changing global landscape.
Journal: JAC-antimicrobial resistance
Published: June 10, 2026
Antibiotic Clinical Trials: A Review of the Past, Present Challenges, and Potential Solutions.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 02, 2026
Evaluating emerging molecular diagnostics for severe infections in neutropenic patients with hematological malignancies.
Journal: Expert review of molecular diagnostics
Published: May 11, 2026
Implementation of pathogen genomics in clinical microbiology laboratories.
Journal: Clinical microbiology reviews
Published: April 27, 2026
Novel transposon Tn8026 acts as a global driver of transmissible linezolid resistance in Enterococcus via a linear plasmid.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
Enterovirus-related central nervous system infections in Queensland, Australia: A 23-year spatiotemporal analysis (2000-2022).
Journal: Infection, disease & health
Published: February 15, 2026
Evaluating the efficiency of platform trials relative to stand-alone trials: a simulation study for the evaluation of new antibacterials.
Journal: The Journal of antimicrobial chemotherapy
Published: February 14, 2026
A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 11, 2026
Precision diagnostics for MBLs: the true game changer in treating antimicrobial resistance - Authors' reply.
Journal: The Lancet. Infectious diseases
Published: January 07, 2026
Last Updated: 09/26/2026